3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer

NCT00077415 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: triapine

Sponsor

Cancer Therapeutics Research Group

Collaborators

[object Object]